Stay updated on Sparsentan in IgA Nephropathy: Clinical Trial
Sign up to get notified when there's something new on the Sparsentan in IgA Nephropathy: Clinical Trial page.

Latest updates to the Sparsentan in IgA Nephropathy: Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe study page’s displayed update/version information has been refreshed, showing newer last update dates and an updated revision identifier. No substantive details about the clinical trial itself appear to be changed.SummaryDifference0.1%

- Check20 days agoChange DetectedAdded the 2026 Clin J Am Soc Nephrol publication by Heerspink et al. to the study's publications. Replaced the 2025 online-ahead-of-print reference with the final article and updated the revision to v3.5.2.SummaryDifference0.0%

- Check27 days agoNo Change Detected
- Check49 days agoChange DetectedRevision label updated from v3.4.3 to v3.5.0. This change does not affect study details or user-facing content.SummaryDifference0.0%

- Check56 days agoChange DetectedRevision tag updated from v3.4.2 to v3.4.3; no study information appears to be altered.SummaryDifference0.0%

- Check77 days agoChange DetectedAdded a new publication citation under Publications: 'Association between Complete Proteinuria Remission and Kidney Function in the Phase 3 PROTECT Trial of Sparsentan in IgA Nephropathy' (Clin J Am Soc Nephrol, 2025).SummaryDifference0.0%

- Check84 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2; no visible changes to core content or layout were observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Sparsentan in IgA Nephropathy: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sparsentan in IgA Nephropathy: Clinical Trial page.